Formidable Asset Management LLC Trims Stock Holdings in Chemed Corporation $CHE

Formidable Asset Management LLC lowered its stake in Chemed Corporation (NYSE:CHE) by 13.9% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,447 shares of the company’s stock after selling 2,334 shares during the quarter. Chemed comprises 0.9% of Formidable Asset Management LLC’s portfolio, making the stock its 25th biggest holding. Formidable Asset Management LLC’s holdings in Chemed were worth $5,457,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CHE. Monetary Solutions Ltd bought a new position in Chemed during the fourth quarter valued at $25,000. Los Angeles Capital Management LLC bought a new stake in shares of Chemed in the 4th quarter worth about $26,000. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the 4th quarter valued at about $27,000. Global Retirement Partners LLC raised its position in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after buying an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC raised its position in shares of Chemed by 800.0% during the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after buying an additional 96 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by company insiders.

Chemed Trading Down 0.3%

Shares of CHE opened at $461.88 on Monday. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.77. The company has a market cap of $6.13 billion, a P/E ratio of 25.17, a P/E/G ratio of 1.74 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The company’s fifty day simple moving average is $426.41 and its 200-day simple moving average is $425.04.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the business earned $5.63 EPS. The business’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, analysts expect that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Wall Street Analyst Weigh In

CHE has been the subject of several recent research reports. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Finally, Royal Bank Of Canada lifted their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.